Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens

Abhishek Maiti; Caitlin R. Rausch; Jorge E. Cortes; Naveen Pemmaraju; Naval G. Daver; Farhad Ravandi; Guillermo Garcia-Manero; Gautam Borthakur; Kiran Naqvi; Maro Ohanian; Nicholas J. Short; Yesid Alvarado; Tapan M. Kadia; Koichi Takahashi; Musa Yilmaz; Nitin Jain; Steven Kornblau; Guillermo Montalban-Bravo; Koji Sasaki; Michael Andreeff; Prithviraj Bose; Alessandra Ferrajoli; Ghayas C. Issa; Elias J. Jabbour; Lucia Masarova; Philip A. Thompson; Sa Wang; Sergej Konoplev; Sherry A. Pierce; Jing Ning; Wei Qiao; John S. Welch; Hagop M. Kantarjian; Courtney D. DiNardo; Marina Y. Konopleva

doi:10.3324/haematol.2020.252569

Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens

Abhishek Maiti
, Caitlin R. Rausch
, Jorge E. Cortes
, Naveen Pemmaraju
, Naval G. Daver
, Farhad Ravandi
, Guillermo Garcia-Manero
, Gautam Borthakur
, Kiran Naqvi
, Maro Ohanian
, Nicholas J. Short
, Yesid Alvarado
, Tapan M. Kadia
, Koichi Takahashi
, Musa Yilmaz
, Nitin Jain
, Steven Kornblau
, Guillermo Montalban-Bravo
, Koji Sasaki
, Michael Andreeff

Prithviraj Bose, Alessandra Ferrajoli, Ghayas C. Issa, Elias J. Jabbour, Lucia Masarova, Philip A. Thompson, Sa Wang, Sergej Konoplev, Sherry A. Pierce, Jing Ning, Wei Qiao, John S. Welch, Hagop M. Kantarjian, Courtney D. DiNardo, Marina Y. Konopleva

Research output: Contribution to journal › Letter › peer-review

147 Scopus citations

Original language	English
Pages (from-to)	894-898
Number of pages	5
Journal	Haematologica
Volume	106
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2020.252569
State	Published - Mar 2021

Access to Document

10.3324/haematol.2020.252569

Cite this

Maiti, A., Rausch, C. R., Cortes, J. E., Pemmaraju, N., Daver, N. G., Ravandi, F., Garcia-Manero, G., Borthakur, G., Naqvi, K., Ohanian, M., Short, N. J., Alvarado, Y., Kadia, T. M., Takahashi, K., Yilmaz, M., Jain, N., Kornblau, S., Montalban-Bravo, G., Sasaki, K., ... Konopleva, M. Y. (2021). Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens. Haematologica, 106(3), 894-898. https://doi.org/10.3324/haematol.2020.252569

@article{42383eca014f499cbcf10555929f815f,

title = "Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens",

author = "Abhishek Maiti and Rausch, \{Caitlin R.\} and Cortes, \{Jorge E.\} and Naveen Pemmaraju and Daver, \{Naval G.\} and Farhad Ravandi and Guillermo Garcia-Manero and Gautam Borthakur and Kiran Naqvi and Maro Ohanian and Short, \{Nicholas J.\} and Yesid Alvarado and Kadia, \{Tapan M.\} and Koichi Takahashi and Musa Yilmaz and Nitin Jain and Steven Kornblau and Guillermo Montalban-Bravo and Koji Sasaki and Michael Andreeff and Prithviraj Bose and Alessandra Ferrajoli and Issa, \{Ghayas C.\} and Jabbour, \{Elias J.\} and Lucia Masarova and Thompson, \{Philip A.\} and Sa Wang and Sergej Konoplev and Pierce, \{Sherry A.\} and Jing Ning and Wei Qiao and Welch, \{John S.\} and Kantarjian, \{Hagop M.\} and DiNardo, \{Courtney D.\} and Konopleva, \{Marina Y.\}",

note = "Funding Information: Funding: this study was supported in part by the MD Anderson Cancer Center Support Grant CA016672 from the National Cancer Institute, and Research Project Grant Program (R01CA235622) from the National Institutes of Health.",

year = "2021",

month = mar,

doi = "10.3324/haematol.2020.252569",

language = "English",

volume = "106",

pages = "894--898",

journal = "Haematologica",

issn = "0390-6078",

number = "3",

}

Maiti, A, Rausch, CR, Cortes, JE, Pemmaraju, N, Daver, NG, Ravandi, F, Garcia-Manero, G, Borthakur, G, Naqvi, K, Ohanian, M, Short, NJ, Alvarado, Y, Kadia, TM, Takahashi, K, Yilmaz, M, Jain, N, Kornblau, S, Montalban-Bravo, G, Sasaki, K, Andreeff, M, Bose, P, Ferrajoli, A, Issa, GC, Jabbour, EJ, Masarova, L, Thompson, PA, Wang, S, Konoplev, S, Pierce, SA, Ning, J, Qiao, W, Welch, JS, Kantarjian, HM, DiNardo, CD & Konopleva, MY 2021, 'Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens', Haematologica, vol. 106, no. 3, pp. 894-898. https://doi.org/10.3324/haematol.2020.252569

TY - JOUR

T1 - Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens

AU - Maiti, Abhishek

AU - Rausch, Caitlin R.

AU - Cortes, Jorge E.

AU - Pemmaraju, Naveen

AU - Daver, Naval G.

AU - Ravandi, Farhad

AU - Garcia-Manero, Guillermo

AU - Borthakur, Gautam

AU - Naqvi, Kiran

AU - Ohanian, Maro

AU - Short, Nicholas J.

AU - Alvarado, Yesid

AU - Kadia, Tapan M.

AU - Takahashi, Koichi

AU - Yilmaz, Musa

AU - Jain, Nitin

AU - Kornblau, Steven

AU - Montalban-Bravo, Guillermo

AU - Sasaki, Koji

AU - Andreeff, Michael

AU - Bose, Prithviraj

AU - Ferrajoli, Alessandra

AU - Issa, Ghayas C.

AU - Jabbour, Elias J.

AU - Masarova, Lucia

AU - Thompson, Philip A.

AU - Wang, Sa

AU - Konoplev, Sergej

AU - Pierce, Sherry A.

AU - Ning, Jing

AU - Qiao, Wei

AU - Welch, John S.

AU - Kantarjian, Hagop M.

AU - DiNardo, Courtney D.

AU - Konopleva, Marina Y.

N1 - Funding Information: Funding: this study was supported in part by the MD Anderson Cancer Center Support Grant CA016672 from the National Cancer Institute, and Research Project Grant Program (R01CA235622) from the National Institutes of Health.

PY - 2021/3

Y1 - 2021/3

UR - https://www.scopus.com/pages/publications/85102127991

U2 - 10.3324/haematol.2020.252569

DO - 10.3324/haematol.2020.252569

M3 - Letter

C2 - 32499238

AN - SCOPUS:85102127991

SN - 0390-6078

VL - 106

SP - 894

EP - 898

JO - Haematologica

JF - Haematologica

IS - 3

ER -

Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens

Access to Document

Other files and links

Cite this